go back

SCHINDLER DISEASE, TYPE I

SCHINDLER DISEASE, TYPE I
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE I; SCHINDLER DISEASE, TYPE III, INCLUDED
609241
OMIM = Online Mendelian Inheritance of Men
3137
Alpha-N-acetylgalactosaminidase
3.2.1.49
22q13.2
E77.1
rare
autosomal recessive
mutation in the alpha-N-acetylgalactosaminidase gene (NAGA)
type I: Schindler disease, infantile onset neuroaxonal dystrophy
type II:Kanzaki disease, adult-onset peripheral neuroaxonal degeneration, angiokeratoma corporis diffusum and mild intellectual impairment may present as a non-disease (present healthy case) [Bakker HD et al. 2001]
type III: intermediate form
Laboratory findings    alpha-N-Acetylgalactosaminidase dec (fibroblasts)
    alpha-N-Acetylgalactosaminidase dec (lymphoblasts)
    alpha-N-Acetylgalactosaminidase dec (plasma)
    Glycopeptides inc (urine)
    Oligosaccharides inc (urine)
Symptoms    blindness, visual loss, visual impairment
    cataract
    cerebellar atrophy or hypoplasia
    cerebral atrophy
    contractures, joints
    CT, brain, abnormalities [-]
    decreased muscle volume, atrophy or hypoplasia
    developmental delay
    EEG abnormalities [-]
    epilepsy
    hyperreflexia
    hypotonia
    mental retardation
    motor retardation
    MRI, brain, abnormalities [-]
    myoclonus
    neurological deterioration
    normal at birth
    nystagmus
    onset, childhood
    onset, infancy
    optic atrophy
    seizures
    strabismus